3. Zyprexa - Top 10 Warnings and Recalls
Drug: Zyprexa
2006 sales: $4.4 billion
Manufacturer: Eli Lilly
Safety concern: Warning; weight gain, metabolic problems
Related Articles:
> Lilly strengthens Zyprexa warnings. Report
> Study: 86% of docs cut Zyprexa use. Report
> Lilly to pay $500M to settle Zyprexa claims. Report
> Lilly ignored Zyprexa safety data on weight, blood sugar. Report
> Lilly accused of promoting off-label Zyprexa use. Report
> NYT accuses Lilly of hiding safety problems. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: